SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-22-016812
Filing Date
2022-04-29
Accepted
2022-04-29 16:09:45
Documents
13
Period of Report
2022-04-28
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K hsto-8k_20220428.htm   iXBRL 8-K 41273
2 EX-10.1 hsto-ex101_6.htm EX-10.1 90594
  Complete submission text file 0001564590-22-016812.txt   278100

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA hsto-20220428.xsd EX-101.SCH 5601
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE hsto-20220428_lab.xml EX-101.LAB 19324
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hsto-20220428_pre.xml EX-101.PRE 11495
7 EXTRACTED XBRL INSTANCE DOCUMENT hsto-8k_20220428_htm.xml XML 3547
Mailing Address 10655 SORRENTO VALLEY ROAD SUITE 200 San Diego CA 92121
Business Address 10655 SORRENTO VALLEY ROAD SUITE 200 San Diego CA 92121 (858) 526-3100
Histogen Inc. (Filer) CIK: 0001383701 (see all company filings)

IRS No.: 203183915 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36003 | Film No.: 22875384
SIC: 2834 Pharmaceutical Preparations